statistiche ricercatore

Continente	#
NA - Nord America	400
AS - Asia	332
EU - Europa	279
SA - Sud America	96
AF - Africa	14
OC - Oceania	2
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.124

Nazione	#
US - Stati Uniti d'America	379
SG - Singapore	121
IT - Italia	120
BR - Brasile	79
CN - Cina	72
HK - Hong Kong	44
RU - Federazione Russa	34
DE - Germania	25
VN - Vietnam	24
GB - Regno Unito	22
IN - India	19
SE - Svezia	17
FR - Francia	14
CA - Canada	12
FI - Finlandia	12
JP - Giappone	9
BD - Bangladesh	8
AR - Argentina	7
ID - Indonesia	6
HU - Ungheria	5
PL - Polonia	5
AT - Austria	4
IL - Israele	4
NL - Olanda	4
UZ - Uzbekistan	4
ZA - Sudafrica	4
AE - Emirati Arabi Uniti	3
CI - Costa d'Avorio	3
CZ - Repubblica Ceca	3
EC - Ecuador	3
ES - Italia	3
MX - Messico	3
NO - Norvegia	3
AU - Australia	2
AZ - Azerbaigian	2
BE - Belgio	2
CO - Colombia	2
IQ - Iraq	2
IR - Iran	2
JM - Giamaica	2
KR - Corea	2
LT - Lituania	2
MD - Moldavia	2
PH - Filippine	2
PK - Pakistan	2
SN - Senegal	2
TR - Turchia	2
UY - Uruguay	2
CL - Cile	1
CR - Costa Rica	1
DZ - Algeria	1
EG - Egitto	1
GT - Guatemala	1
IE - Irlanda	1
KE - Kenya	1
KZ - Kazakistan	1
LB - Libano	1
MA - Marocco	1
ML - Mali	1
NP - Nepal	1
PA - Panama	1
PR - Porto Rico	1
PY - Paraguay	1
SA - Arabia Saudita	1
SI - Slovenia	1
SR - Suriname	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.124

Nome	#
Harmaline-based scaffold as Human Caseinolytic Protease P (hClpP) inducers for Diffuse Intrinsic Pontine Glioma (DIPG) treatment	174
A further pocket or conformational plasticity by mapping COX-1 catalytic site through modified-mofezolac structure-inhibitory activity relationships and their antiplatelet behavior	132
Molecular simplification of natural products: Synthesis, antibacterial activity, and molecular docking studies of berberine open models	117
Cyclooxygenase-1 Inhibition: A Promising Theragnostic Approach for Ovarian Cancer	115
Fluorescent imaging probes for in vivo ovarian cancer targeted detection and surgery	110
Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment	90
Repurposing of natural origin compounds as HsClpP inducers to treat diffuse midline glioma (DMG)	86
COX-1 INHIBITORS AS ANTI-PLATELET AGENTS IN COVID-19	86
Fluorochrome Selection for Imaging Intraoperative Ovarian Cancer Probes	85
CHALLENGE TRANSABILITY OF “IN VITRO” TO “IN VIVO”: GENE-EXPRESSION BIOMARKERS AND FLUORESCENT IMAGE-GUIDED SURGERY PROBES IDENTIFICATION FOR OVARIAN CANCER	83
DIPG-27. Diffuse Intrinsic Pontine Glioma (DIPG) challenge: from gene expression profile to drug.	69
Therapeutic Role of Cyclooxygenase-1 (COX-1) Inhibition, Challenging the Conventional View of COX-1 as Purely Constitutive	18
Totale	1.165

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	3	0	0	0	0	0	0	0	0	0	0	0	3
2021/2022	9	4	0	0	0	0	1	0	0	1	1	1	1
2022/2023	31	2	3	1	1	4	3	1	9	6	1	0	0
2023/2024	140	1	4	5	7	5	5	1	1	82	16	1	12
2024/2025	313	16	6	9	12	21	19	57	36	23	29	27	58
2025/2026	669	88	31	41	75	71	39	74	29	86	80	46	9
Totale													1.165